UK: NICE rejects Johnson and Johnson nasal spray for depression in NHS Medical Dialogues Bureau29 Jan 2020 7:08 AMThe National Institute for Health and Care Excellence (NICE), which determines if a drug is included in Britain's National Healthcare System (NHS),...
Cipla gets no USFDA observations for Indore facility Farhat Nasim18 May 2019 4:15 AMThe US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus Medical Dialogues Bureau30 April 2019 3:45 AMNew Delhi: GlaxoSmithKline (GSK) has won the US Food and Drug Administration's (USFDA) approval for its Benlysta (belimumab) intravenous (IV) infusion...
Using AI to detect mental health disorders likely to be counterproductive Medical Dialogues Bureau30 April 2019 3:30 AMAI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be...
Allergan depression drug fails trial, loses over Rs 100 crore expected sales Farhat Nasim8 March 2019 3:30 AMStanicky said the data was the most anticipated release of the year and likely means that Allergan will lose what had been expected to be a $1 billion...
Sage shares surge as depression drug succeeds in mid-stage trial Ruby Khatun Khatun9 Dec 2017 4:00 AMDrug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the...
FDA approves first drug in US with digital ingestion tracking Ruby Khatun Khatun15 Nov 2017 5:15 AMThe U.S. Food and Drug Administration (FDA) approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole...
